Invasive brain-computer interfaces (BCIs) allow for direct communication between the brain and external devices, offering immense potential for restoring lost functions and even enhancing brain capabilities. Recent advances are bringing this emerging technology closer to widespread clinical use. Invasive BCIs involve surgically implanted electrodes to record from or stimulate the brain. This allows for much …
Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide. It is characterized by hallucinations, delusions, disorganized thinking and behavior, and impaired cognitive functioning. Current treatments with antipsychotic medications are helpful but have significant limitations, especially for cognitive deficits and negative symptoms like social withdrawal and lack of motivation. This has driven …
A new case study provides initial evidence that transcranial direct current stimulation (tDCS) may be an effective treatment option for trichotillomania, also known as hair pulling disorder. The study tested an intensified, repeated tDCS protocol targeting the supplementary motor area and dorsolateral prefrontal cortex in a 25-year-old woman with trichotillomania. After 16 sessions over 20 …
Insomnia is a highly prevalent sleep disorder affecting up to 35% of the general population – and can significantly impair quality of life. Researchers have been investigating new non-pharmacological treatment options like transcranial electric stimulation (TES) and repetitive transcranial magnetic stimulation (rTMS) to treat insomnia symptoms. A new meta-analysis published in Frontiers in Psychiatry reviewed …
Neuralink, a neurotechnology company founded by Elon Musk, has developed a novel brain-machine interface system with unprecedented electrode density and bandwidth. In a recent white paper, Neuralink scientists describe their progress towards a scalable, high-performance implantable device for interfacing with the brain. The key facts: Neuralink’s device has over 3,000 electrodes per array, an order …
Neuralink, a neurotechnology company founded by Elon Musk in 2016, is developing an innovative brain-machine interface (BMI) device that aims to enhance brain function and revolutionize neurosurgery. Early testing on animals shows promise, but human trials are still needed to determine safety and efficacy. If proven viable, Neuralink’s technology could transform treatment for neurological disorders. …
Neuromodulation techniques that stimulate the nervous system through electric current are revolutionizing the treatment of neurological and psychiatric disorders like depression, movement disorders, and chronic pain. These techniques allow for precisely targeted treatment of specific brain regions. Key facts: Neuromodulation techniques include invasive methods like deep brain stimulation (DBS) as well as non-invasive methods like …
Transcranial alternating current stimulation (TACS) is an emerging non-invasive brain stimulation technique that shows promise for enhancing cognition and treating psychiatric conditions like depression and schizophrenia. Recent research indicates TACS may improve symptoms and function by modulating brain oscillations and connectivity. Key facts: TACS delivers alternating electrical current to the brain at specific frequencies, which …
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders affecting children. A new randomized controlled trial published in the Journal of Korean Medical Science suggests that mobile neurofeedback training may help improve attention and reduce symptoms in children with ADHD. Key Takeaways: 74 children aged 8-15 with ADHD participated in a …
Vagus nerve stimulation (VNS) is an emerging form of brain stimulation showing promise for treating depression. Though still considered experimental, VNS has a long history dating back over 100 years. Recent advances are unlocking its potential as a new tool for mood disorders. Key Facts: VNS stimulates the vagus nerve, which connects to emotion regulation …
